Skip Navigation

Human Molecular Genetics 2006 15(Review Issue 2):R103-R109; doi:10.1093/hmg/ddl179
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tybulewicz, V. L.J.
Right arrow Articles by Fisher, E. M.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tybulewicz, V. L.J.
Right arrow Articles by Fisher, E. M.C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

New techniques to understand chromosome dosage: mouse models of aneuploidy

Victor L.J. Tybulewicz1,* and Elizabeth M.C. Fisher2,*

1 Division of Immune Cell Biology, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK and 2 Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, UK

* To whom correspondence should be addressed. Tel: +44 2088162184; Fax: +44 2089064477; Email: vtybule{at}nimr.mrc.ac.uk (V.L.J.T.) or Tel: +44 2076762037; Fax: +44 2076762180; Email: e.fisher{at}prion.ucl.ac.uk ( E.M.C.F.)

Received June 29, 2006; Accepted July 12, 2006

Aberrations in human chromosome copy number and structure are common and extremely deleterious. Their downstream effects on phenotype are caused by aberrant dosage of sequences in the affected regions. However, we know little about why the abnormal gene copy number causes disease or why specific features result from deficits in specific chromosomes. Mice are the organism of choice to help us try to tease apart the complex relationships between genotype and phenotype in aneuploidy and segmental aneusomy syndromes. As new technologies such as chromosome engineering and the creation of transchromosomic mice become routine, these will help us identify individual dosage-sensitive genes that are causative in specific syndromes and will enable us to produce mouse models to accurately recapitulate human chromosomal disorders.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 DMMHome page
E. M. C. Fisher, E. Lana-Elola, S. D. Watson, G. Vassiliou, and V. L. J. Tybulewicz
New approaches for modelling sporadic genetic disease in the mouse
Dis. Model. Mech., September 1, 2009; 2(9-10): 446 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
M. Dierssen, Y. Herault, and X. Estivill
Aneuploidy: From a Physiological Mechanism of Variance to Down Syndrome
Physiol Rev, July 1, 2009; 89(3): 887 - 920.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
F. K. Wiseman, K. A. Alford, V. L.J. Tybulewicz, and E. M.C. Fisher
Down syndrome--recent progress and future prospects
Hum. Mol. Genet., April 15, 2009; 18(R1): R75 - R83.
[Abstract] [Full Text] [PDF]

Home page
 DMMHome page
D. Nguyen and T. Xu
The expanding role of mouse genetics for understanding human biology and disease
Dis. Model. Mech., July 1, 2008; 1(1): 56 - 66.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.